Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-d-glucose and positron emission tomography: frustration or future

This publication has 25 references indexed in Scilit:

• Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C]tyrosine and fluorine-18-fluorodeoxyglucose.
  1992
• Clinical application of PET for the evaluation of brain tumors.
  1991
• MONITORING LIVER-TUMOR THERAPY WITH [F-18] FDG POSITRON EMISSION TOMOGRAPHY
  1990
• [Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET].
  1989
• Recurrence of colorectal tumors: PET evaluation.
  Radiology, 1989
• Early and late stage positron emission tomography (PET) studies on the haemocirculation and metabolism of seemingly normal brain tissue in patients with gliomas following radiochemotherapy
  Acta Neurochirurgica, 1988
• New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
  1986
• Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose
  European Journal of Nuclear Medicine and Molecular Imaging, 1986
• Positron emission tomography in the study of human tumors
  Seminars in Nuclear Medicine, 1984
• Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
  Radiology, 1982